IT1318376B1 - Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo. - Google Patents

Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.

Info

Publication number
IT1318376B1
IT1318376B1 IT2000MI000440A ITMI20000440A IT1318376B1 IT 1318376 B1 IT1318376 B1 IT 1318376B1 IT 2000MI000440 A IT2000MI000440 A IT 2000MI000440A IT MI20000440 A ITMI20000440 A IT MI20000440A IT 1318376 B1 IT1318376 B1 IT 1318376B1
Authority
IT
Italy
Prior art keywords
controlled release
active principle
solid forms
oral solid
release containing
Prior art date
Application number
IT2000MI000440A
Other languages
English (en)
Inventor
Vittorino Ravelli
Romano Rivolta
Francesco Montano
Original Assignee
Pharmatec Internat S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmatec Internat S R L filed Critical Pharmatec Internat S R L
Priority to IT2000MI000440A priority Critical patent/IT1318376B1/it
Publication of ITMI20000440A0 publication Critical patent/ITMI20000440A0/it
Priority to AU2001248336A priority patent/AU2001248336A1/en
Priority to PCT/EP2001/002539 priority patent/WO2001066094A1/en
Publication of ITMI20000440A1 publication Critical patent/ITMI20000440A1/it
Application granted granted Critical
Publication of IT1318376B1 publication Critical patent/IT1318376B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2000MI000440A 2000-03-07 2000-03-07 Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo. IT1318376B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2000MI000440A IT1318376B1 (it) 2000-03-07 2000-03-07 Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
AU2001248336A AU2001248336A1 (en) 2000-03-07 2001-03-07 Controlled release oral solid forms containing mesalazine as active agent
PCT/EP2001/002539 WO2001066094A1 (en) 2000-03-07 2001-03-07 Controlled release oral solid forms containing mesalazine as active agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000440A IT1318376B1 (it) 2000-03-07 2000-03-07 Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.

Publications (3)

Publication Number Publication Date
ITMI20000440A0 ITMI20000440A0 (it) 2000-03-07
ITMI20000440A1 ITMI20000440A1 (it) 2001-09-07
IT1318376B1 true IT1318376B1 (it) 2003-08-25

Family

ID=11444340

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI000440A IT1318376B1 (it) 2000-03-07 2000-03-07 Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.

Country Status (3)

Country Link
AU (1) AU2001248336A1 (it)
IT (1) IT1318376B1 (it)
WO (1) WO2001066094A1 (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
WO2004062577A2 (en) * 2003-01-03 2004-07-29 Shire Laboratories Inc. Two or more enteric materials to regulate drug release
WO2004087113A1 (en) * 2003-04-04 2004-10-14 Ranbaxy Laboratories Limited Pharmaceutical compositions for colon specific delivery
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
CN101287443B (zh) 2005-07-29 2013-05-29 斯蒂茨廷格罗宁根药物研究中心 pH控制的脉冲释放系统、其制备方法和用途
ITMI20070022A1 (it) 2007-01-09 2008-07-10 I P S Internat Products & Services Srl Formulazione di prodotti solidi a rilascio controllato per uso orale in bustine monodose e relativo procedimento di preparazione
EP2367421A4 (en) * 2008-12-17 2013-03-13 Altheus Therapeutics Inc ORAL FORMULAS
IT1395143B1 (it) 2009-08-06 2012-09-05 Sofar Spa Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento.
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
MY176758A (en) * 2013-08-06 2020-08-21 Tasly Pharmaceutical Group Co Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof
IT201800011120A1 (it) 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
JPH072650A (ja) * 1993-06-18 1995-01-06 Tanabe Seiyaku Co Ltd 放出部位制御型製剤
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes

Also Published As

Publication number Publication date
ITMI20000440A1 (it) 2001-09-07
WO2001066094A1 (en) 2001-09-13
ITMI20000440A0 (it) 2000-03-07
AU2001248336A1 (en) 2001-09-17

Similar Documents

Publication Publication Date Title
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
DE60109260D1 (de) Drucksystem
DE60121251D1 (de) Pedalmechanismus
ITMI20001603A0 (it) Formulazioni farmaceutiche solide orali a rilascio multifasico ph-dipendente
IT1318376B1 (it) Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
DE60009106D1 (de) Mikrokapseln mit veränderlicher freisetzung
DE60122229D1 (de) Trennfilm
NO20021452L (no) Orale kontrollerte frigivelsesformuleringer
ATE256918T1 (de) Metall-luft-batterie
DE60005777D1 (de) Drucksystem
IT249369Y1 (it) Custodia perfezionata per telecamere.
ES1046835Y (es) Fusil para pesca subacuatica.
IT1313589B1 (it) Composizioni a rilascio controllato di paracetamolo.
ES1046590Y (es) Gabeta ligera perfeccionada.
IT1320100B1 (it) Formulazioni farmaceutiche a rilascio controllato di levodopa ecarbidopa.
TR199700568A3 (tr) Sivama döküm.
SE0003142D0 (sv) APM - Aritius projekt modell
IT250810Y1 (it) Porta uovo facile.
ES1045931Y (es) Cargador de pacas perfeccionado.
ES1045025Y (es) Muñeco desmontable.
ES1045972Y (es) Dispositivo aplicable a los tipos de colmenas estandar existentes.
ES1045934Y (es) Andamio desmontable perfeccionado.
ES1043162Y (es) Freno instantaneo para flexometro.
IT249551Y1 (it) Cartellina facile porta documenti.
ES1043641Y (es) Flexometro perfeccionado.